Dr. Peter Pronovost, Johns Hopkins University, provides three video commentaries on CDC’s recent Vital Signs report on central line-associated bloodstream infections in hospitals and dialysis facilities. Dr. Pronovost’s commentary is provided below. Click on the video to watch.
Transcript: Where do we go from here?
“We must ensure that all patients in ICUs receive best practices. We have seen dramatic reductions in infections in all types of ICUs – teaching and community, large and small, urban and rural. Yet the results are patchy. Some ICUs remain with high CLABSI rates.
We must apply these lessons to reduce other types of preventable harm such as ventilator-associated pneumonia.
We are also working to address the dialysis issue. Our research team at Johns Hopkins is working to implement this safety program to reduce CLABSI in dialysis patients in a pilot study in Maryland. When successful, it will likely be expanded nationally.
And science must guide us. We need to learn how to ensure clinicians comply with evidence-based practices, how ICU clinicians changed their culture, and how other clinicians may also. We need to learn why some types of organisms have been reduced less than others, and what we can do about it. We need to ensure we identify effective interventions to prevent other types of infections, develop valid and feasible measures of harm, create a pipeline of new programs that are every bit as effective as the program to prevent ICU CLABSI.”
More information on the CDC Vital Signs release.